Research status of E3 ubiquitin ligase Smurf2 and related signaling pathways in glioma

doi:10.3868/j.issn.2096-0689.2020.02.001

Journal of Translational Neuroscience

2020, Vol. 5

Issue (2) : 1-8 https://doi.org/10.3868/j.issn.2096-0689.2020.02.001

Review

Research status of E3 ubiquitin ligase Smurf2 and related signaling pathways in glioma

Qianxu Jin, Zongmao Zhao^*

The Second Hospital of Hebei Medical University, Shijiazhuang 050051, China

Download: PDF(9948 KB)
Export: BibTeX | EndNote | Reference Manager | ProCite | RefWorks

Abstract Glioma is the tumor with the highest incidence in the brain, and it is eager to seek new and effective treatment. The interaction of ubiquitination and deubiquitination regulates many cell activities in organisms, and participates in tumor occurrence, development, migration, invasion and other processes. This article summarized the progress of E3 ubiquitination ligase smad ubiquitination regulatory factor 2 (Smurf2) and glioma-related signaling pathways to assist clinical diagnosis and treatment of glioma.

Keywords glioma smad ubiquitination regulatory factor 2 (Smurf2) ubiquitin ligase signaling pathway

Issue Date: 25 June 2020

Cite this article:

Qianxu Jin, Zongmao Zhao. Research status of E3 ubiquitin ligase Smurf2 and related signaling pathways in glioma[J]. Journal of Translational Neuroscience,2020, 5(2): 1-8.

URL:

https://academic.hep.com.cn/jtn/EN/10.3868/j.issn.2096-0689.2020.02.001
https://academic.hep.com.cn/jtn/EN/Y2020/V5/I2/1

[1]	Qianxu Jin, Zongmao Zhao. Human umbilical cord mesenchymal stem cells as cell carriers in the treatment of gliomas: research status and prospects[J]. Journal of Translational Neuroscience, 2020, 5(2): 22-33.
[2]	Xin Wang, Bin Wang. Research progress of immunotherapies in malignant glioma[J]. Journal of Translational Neuroscience, 2020, 5(2): 9-21.

Viewed

Full text

Abstract

Cited

Shared

Discussed